This concept is also supported from our immune IHC analysis, in which we found in all the AML samples analyzed almost 100% of the blasts are highly positive for CD84, but this positivity was somehow diluted when the samples were analyzed by both flow cytometry and CyTOF. This evidence concerns the gene CD84 and acute myeloid leukemia.